Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-26

Clinical Trial Update: Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating epinephrine infusion as a preventive measure against maternal hypotension during cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Postspinal Hypotension, Cesarean Delivery | Phase 4 | Status: UNKNOWN